Dendreon Breast Cancer Vaccine Generates Strong Immune Response and Shows Preliminary Evidence of Clinical Benefit in Women with Advanced, Metastatic Disease.
Business Wire › December 12, 2002
Linked as:
Extract
Dendreon Breast Cancer Vaccine Generates Strong Immune Response and Shows Preliminary Evidence of Clinical Benefit in Women with Advanced, Metastatic Disease.
Business Editors/Health/Medical Writers
25th Annual San Antonio Breast Cancer Symposium BIOWIRE2K SAN ANTONIO--(BUSINESS WIRE)--Dec. 12, 2002 Data presented today at San Antonio Breast Cancer Symposium Dendreon Corporation (Nasdaq:DNDN) today a...See the full content of this document
Sponsored links
